Investing Stocks بايو-تكني · TECH Novo Nordisk licenses Nanexa drug tech in deal worth up to €1.17 bln Sep 25, 2026 9:30 AM · Investing Novo Nordisk licenses Nanexa drug tech in deal worth up to €1.17 bln Original source: Investing